Enbrel 25 mg solution for injection in pre-filled syringe

DRUG3 trials

Sponsors

Giannina Gaslini Institute For Scientific Hospitalization And Care, IRCCS Istituto Giannina Gaslini, Duke Clinical Research Institute

Conditions

Juvenile Idiopathic ArthritisJuvenile idiopathic arthritisjuvenile idiopathic arthritis

Phase 3

Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS

Not yet recruitingCTIS2023-505051-43-00

Giannina Gaslini Institute For Scientific Hospitalization And Carejuvenile idiopathic arthritis

Target: 260Updated: 2025-09-30

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)

Not yet recruitingCTIS2025-520923-25-00

Duke Clinical Research InstituteJuvenile Idiopathic Arthritis

Target: 30Updated: 2026-02-11

Phase 4

Toward personalized medicine to guide drug withdrawal in children with juvenile idiopathic arthritis in clinical remission: a randomized clinical trial comparing early versus late drug withdrawal combining imaging and multi-Omics.

RecruitingCTIS2024-514732-24-00

IRCCS Istituto Giannina GasliniJuvenile idiopathic arthritis

Start: 2025-04-28Target: 328Updated: 2025-08-26